Anticancer activity of protocatechualdehyde in human breast cancer cells

Journal of Medicinal Food

Volumn 17, Issue 8, 2014, Pages 842-848

  Choi, Jieun ^a   Jiang, Xiaojing ^a   Jeong, Jin Boo ^a   Lee, Seong Ho ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

breast cancer; cyclin D1; protocatechualdehyde; catenin

Indexed keywords

ANTINEOPLASTIC AGENT; BENZALDEHYDE DERIVATIVE; BETA CATENIN; CATECHOL DERIVATIVE; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTOCATECHUALDEHYDE;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; DOWN REGULATION; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZALDEHYDES; BETA CATENIN; BREAST NEOPLASMS; CATECHOLS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN D1; DOWN-REGULATION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; NF-KAPPA B;

EID: 84905862475     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.0159     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Zhou Z, Liu Y, Miao AD, Wang SQ: Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur J Pharmacol 2005;513:1-8.
3. Etoh H, Murakami K, Yogoh T, Ishikawa H, Fukuyama Y, Tanaka H: Anti-oxidative compounds in barley tea. Biosci Biotechnol Biochem 2004;68:2616-2618.
4. Chang ZQ, Gebru E, Lee SP, et al.: In vitro antioxidant and anti-inflammatory activities of protocatechualdehyde isolated from Phellinus gilvus. J Nutr Sci Vitaminol (Tokyo) 2011;57: 118-122.
5. Wei G, Guan Y, Yin Y, et al.: Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro. Inflammation 2013;36:592-602.
6. Jeong JB, Lee SH: Protocatechualdehyde possesses anti-cancer activity through downregulating cyclin D1 and HDAC2 in human colorectal cancer cells. Biochem Biophys Res Commun 2013;430: 381-386.
7. Widelitz RB, Jiang TX, Lu J, Chuong CM: Beta-catenin in epithelial morphogenesis: conversion of part of avian foot scales into feather buds with a mutated beta-catenin. Dev Biol 2000;219:98-114.
8. Polakis P: Wnt signaling and cancer. Genes Dev 2000;14:1837-1851.
9. Bienz M: APC: the plot thickens. Curr Opin Genet Dev 1999;9:595-603.
10. Cohen P, Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2001;2:769-776.
11. Shtutman M, Zhurinsky J, Simcha I, et al.: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
12. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999:398:422-426.
13. Cho HH, Song JS, Yu JM, et al.: Differential effect of NFkappa B activity on beta-catenin/Tcf pathway in various cancer cells. FEBS Lett 2008;582:616-622.
14. Deng J, Miller SA, Wang HY, et al.: beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2002;2:323-334.
15. Kim KJ, Kim MA, Jung JH: Antitumor and antioxidant activity of protocatechualdehyde produced from Streptomyces lincolnensis M-20. Arch Pharm Res 2008;31:1572-1577.
16. Lee BH, Yoon SH, Kim YS, Kim SK, Moon BJ, Bae YS: Apoptotic cell death through inhibition of protein kinase CKII activity by 3,4-dihydroxybenzaldehyde purified from Xanthium strumarium. Natural Product Research 2008;22:1441-1450.
17. Behrens J, Jerchow BA, Würtele M, et al.: Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998;280:596-599.
18. Parsons R: Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 2004;15:171-176.
19. Yamaguchi K, Lee SH, Eling TE, Baek SJ: Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway. J Biol Chem 2004;279:49617-49623.
20. Gillett C, Fantl V, Smith R, et al.: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-1817.
21. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, Aggarwal BB: Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002;21:8852-8861.
22. Spinella MJ, Freemantle SJ, Sekula D, Chang JH, Christie AJ, Dmitrovsky E: Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J Biol Chem 1999;274:22013-22018.
23. Huang JW, Shiau CW, Yang YT, et al.: Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol Pharmacol 2005;67:1342-1348.
24. Perkins ND, Gilmore TD: Good cop, bad cop: the different faces of NF-kappa B. Cell Death Differ 2006;13:759-772.
25. Stark LA, Dunlop MG: Nucleolar sequestration of RelA (p65) regulates NF-kappaB-driven transcription and apoptosis. Mol Cell Biol 2005;25:5985-6004.
26. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-6866.
27. Stark LA, Din FV, Zwacka RM, Dunlop MG: Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 2001;15:1273-1275.
28. Kasperczyk H, La Ferla-Brühl K, Westhoff MA, et al.: Betulinic acid as new activator of NF-kappa B: molecular mechanisms and implications for cancer therapy. Oncogene 2005;24:6945-6956.
29. Jeong JB, Yang X, Clark R, Choi J, Baek SJ, Lee SH: A mechanistic study of the proapoptotic effect of tolfenamic acid; involvement of NF-kappaB activation. Carcinogenesis 2013;34: 2350-2360.
30. Cho M, Gwak J, Park S, et al.: Diclofenac attenuates Wnt/betacatenin signaling in colon cancer cells by activation of NF-kappaB. FEBS Lett 2005;579:4213-4218.
31. Kouzmenko AP, Takeyama K, Ito S, et al.: Wnt/β-catenin and estrogen signaling converge in vivo. J Biol Chem 2004;279: 40255-40258.
32. Gupta N, Schmitt F, Grebhardt S, Mayer D: β-catenin is a positive regulator of estrogen receptor-α function in breast cancer cells. Cancers (Basel) 2011;3:2990-3001.